Skip to main content
. 2008 Apr 16;2008(2):CD005589. doi: 10.1002/14651858.CD005589.pub2
progression free survival
Study topotecan PLD RR P value
progression free survival
Gordon 2004a 16.1 17.0 not given 0.095
progression free survival(platium‐sensitive)
Gordon 2004a 23.3 28.9 not given 0.037
progression free survival(platium‐resistant)
Gordon 2004a 13.6 9.1 not given 0.733